CommercialCoverageMedium impact
08.01.08t, Coverage of Anticancer Prescription Oral and Injectable Drugs and Biologics and Supportive Agents
Independence Blue Cross·Oncology, Hematology·Pharmacy
Effective date
Apr 30, 2025
We identified it
Jun 19, 2026
Summary
This is a reissue of the anticancer oral and injectable drugs and biologics coverage policy for commercial plans, effective April 30, 2025. The policy covers prescription cancer medications and supportive agents, though specific changes from the previous version are not detailed in the summary provided.
Action Required
By April 30, 2025: Billing team should review the full reissued policy at the provided URL to identify any changes in coverage criteria, prior authorization requirements, or billing procedures for anticancer prescription drugs and biologics. Update billing protocols and staff training as needed based on the detailed policy content.